EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel SERPINC1 variants in hereditary antithrombin deficiency: first pathogenic deep-intronic variant, revealed by multiple genomic and transcriptomic approaches

P Christian Remmelzwaal, René Mulder, Jelkje J de Boer-Bergsma, Albertus Vinke, Hilde A M Kooistra, Nic J G M Veeger, Albertus T J Wierenga, Jan Jacob Schuringa, Michaël V Lukens, Karina Meijer

Journal of Thrombosis and Haemostasis · 2026-08 · 24 (8) · 2890-2898

DOI: 10.1016/j.jtha.2026.05.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-08. Verfasst von P Christian Remmelzwaal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, University Medical Centre Groningen, Groningen, Netherlands. Electronic address: p.c.remmelzwaal@umcg.nl. Hauptthemen laut MEDLINE: Antithrombin III, Antithrombin III Deficiency, Introns, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Antithrombin deficiency is a rare hereditary predisposition to venous thromboembolism caused by variants in the SERPINC1 gene. In up to 20% of cases, no explanatory variant is identified. OBJECTIVES: This study uncovered novel variants by covering the full SERPINC1 region. METHODS: In this single-center cohort study, we included antithrombin-deficient families in which no SERPINC1 variant had been previously identified. We used multiple genomic and transcriptomic approaches to identify novel variants and assess their pathogenicity. Variants were classified according to SERPINC1-specific American College of Medical Genetics and Genomics criteria. RESULTS: We included 10 families with 42 individuals and identified 3 novel SERPINC1 (NM_000488.4) variants: c.42-209T>G, c.1153+429C>T, and c.916T>G. In addition, we identified an exon 6 deletion of uncertain novelty. All variants cosegregated perfectly. Despite being highly suspect, c.42-209T>G was the only variant of uncertain significance according to American College of Medical Genetics and Genomics criteria, which prompted us to perform functional testing. Prediction tools suggested the introduction of an acceptor splice site at c.42-208, resulting in the inclusion of a pseudoexon with premature stopcodon. We confirmed this aberrant splicing prediction by quantitative polymerase chain reaction and Sanger sequencing of cDNA synthesized from RNA isolated from genomic-edited HepG2 cells. c.42-209T>G leads to a reduction of SERPINC1 transcript levels. CONCLUSION: We report several novel SERPINC1 variants, one of which is the first pathogenic deep-intronic variant causing antithrombin deficiency through aberrant splicing. This finding improves our understanding of the genetic etiology and clinical practice for antithrombin deficiency. In all tested families registered with our institution, an explanatory SERPINC1 variant has now been identified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antithrombin IIIAntithrombin III DeficiencyIntronsTranscriptomeGene Expression ProfilingMutationHumansFemaleGenetic Predisposition to DiseasePedigreeMalePhenotypeAdultMiddle AgedGenetic VariationExonsGenomicsDNA Mutational AnalysisVenous ThromboembolismHep G2 Cells

Stichwörter der Autor:innen

antithrombin IIIantithrombin III deficiencygene editingvenous thromboembolismwhole genome sequencing

Substanzen

Antithrombin IIISERPINC1 protein, human

Autor:innen und Institutionen

  • Department of Haematology, University Medical Centre Groningen, Groningen, Netherlands. Electronic address: p.c.remmelzwaal@umcg.nl.
  • Department of Genetics, University of Groningen, University Medical Centre Groningen, Netherlands.
  • Department of Laboratory Medicine, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.
  • Department of Haematology, University Medical Centre Groningen, Groningen, Netherlands.
  • Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.

Zitieren

APA

Remmelzwaal, P. C., Mulder, R., de Boer-Bergsma, J. J., Vinke, A., Kooistra, H. A. M., Veeger, N. J. G. M., Wierenga, A. T. J., Schuringa, J. J., Lukens, M. V., & Meijer, K. (2026). Novel SERPINC1 variants in hereditary antithrombin deficiency: first pathogenic deep-intronic variant, revealed by multiple genomic and transcriptomic approaches. Journal of Thrombosis and Haemostasis, 24(8), 2890-2898. https://doi.org/10.1016/j.jtha.2026.05.020

Vancouver

Remmelzwaal PC, Mulder R, de Boer-Bergsma JJ, Vinke A, Kooistra HAM, Veeger NJGM, et al. Novel SERPINC1 variants in hereditary antithrombin deficiency: first pathogenic deep-intronic variant, revealed by multiple genomic and transcriptomic approaches. Journal of Thrombosis and Haemostasis. 2026;24(8):2890-2898. doi:10.1016/j.jtha.2026.05.020

BibTeX
@article{Remmelzwaal2026,
  author = {Remmelzwaal, P Christian and Mulder, René and de Boer-Bergsma, Jelkje J and Vinke, Albertus and Kooistra, Hilde A M and Veeger, Nic J G M and Wierenga, Albertus T J and Schuringa, Jan Jacob and Lukens, Michaël V and Meijer, Karina},
  title = {Novel SERPINC1 variants in hereditary antithrombin deficiency: first pathogenic deep-intronic variant, revealed by multiple genomic and transcriptomic approaches},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {8},
  pages = {2890--2898},
  doi = {10.1016/j.jtha.2026.05.020}
}
Kostenlos starten →